Sato H, Takimoto T, Tanaka S, Ogura H, Shiraishi K, Tanaka J
Department of Virology, Cancer Research Institute, Kanazawa, Japan.
J Virol. 1989 Aug;63(8):3555-9. doi: 10.1128/JVI.63.8.3555-3559.1989.
NPC-KT cl.S61, a subclone derived from an epithelial-nasopharyngeal carcinoma hybrid cell line (NPC-KT), showed cytopathic changes characteristic of herpesvirus replication, including formation of multinucleated giant cells and inclusion bodies, when Epstein-Barr virus replicative cycle was induced by 5-iodo-2'-deoxyuridine. Acyclovir (an inhibitor of herpesvirus DNA polymerase), Epstein-Barr virus-immune human serum, or 2-deoxyglucose (an inhibitor of the glycosylation) interfered with syncytium formation, indicating that a virus-specified glycoprotein belonging to the late group is responsible for cell fusion induced by Epstein-Barr virus replication in cl.S61 cells.
NPC-KT cl.S61是从上皮性鼻咽癌杂交细胞系(NPC-KT)衍生而来的一个亚克隆,当用5-碘-2'-脱氧尿苷诱导爱泼斯坦-巴尔病毒复制周期时,它表现出疱疹病毒复制特有的细胞病变变化,包括多核巨细胞和包涵体的形成。阿昔洛韦(一种疱疹病毒DNA聚合酶抑制剂)、爱泼斯坦-巴尔病毒免疫人血清或2-脱氧葡萄糖(一种糖基化抑制剂)会干扰合胞体形成,这表明属于晚期组的病毒特异性糖蛋白是爱泼斯坦-巴尔病毒在cl.S61细胞中复制诱导细胞融合的原因。